These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23176656)

  • 1. Vaccines against Plasmodium vivax: a research challenge.
    Patarroyo MA; Calderón D; Moreno-Pérez DA
    Expert Rev Vaccines; 2012 Oct; 11(10):1249-60. PubMed ID: 23176656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium vivax malaria vaccines: why are we where we are?
    Reyes-Sandoval A; Bachmann MF
    Hum Vaccin Immunother; 2013 Dec; 9(12):2558-65. PubMed ID: 23978931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priorities in research and development of vaccines against Plasmodium vivax malaria.
    Brown GV; Moorthy VS; Reed Z; Mendis K; Arévalo-Herrera M; Alonso P;
    Vaccine; 2009 Dec; 27(52):7228-35. PubMed ID: 19761835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the search for a Plasmodium vivax vaccine.
    Herrera S; Corradin G; Arévalo-Herrera M
    Trends Parasitol; 2007 Mar; 23(3):122-8. PubMed ID: 17258937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investment in malaria research has led to strong pipeline of malaria vaccines, report suggests.
    Constable L
    Expert Rev Vaccines; 2011 Aug; 10(8):1116. PubMed ID: 21961197
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of vaccines for Plasmodium vivax malaria.
    Mueller I; Shakri AR; Chitnis CE
    Vaccine; 2015 Dec; 33(52):7489-95. PubMed ID: 26428453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of Plasmodium vivax vaccine.
    Arévalo-Herrera M; Chitnis C; Herrera S
    Hum Vaccin; 2010 Jan; 6(1):124-32. PubMed ID: 20009526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines against malaria: perspectives from Papua New Guinea.
    Mueller I; Genton B; Betuela I; Alpers MP
    Hum Vaccin; 2010 Jan; 6(1):17-20. PubMed ID: 20173407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview: immunology of malaria and progress in malaria vaccine development.
    Tharavanij S
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():71-87. PubMed ID: 1364871
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
    Ramjanee S; Robertson JS; Franke-Fayard B; Sinha R; Waters AP; Janse CJ; Wu Y; Blagborough AM; Saul A; Sinden RE
    Vaccine; 2007 Jan; 25(5):886-94. PubMed ID: 17049690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses.
    White M; Amino R; Mueller I
    Trends Parasitol; 2017 Apr; 33(4):260-263. PubMed ID: 28077251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platform for Plasmodium vivax vaccine discovery and development.
    Valencia SH; Rodríguez DC; Acero DL; Ocampo V; Arévalo-Herrera M
    Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1(Suppl 1):179-92. PubMed ID: 21881773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium vivax vaccine research - we've only just begun.
    Tham WH; Beeson JG; Rayner JC
    Int J Parasitol; 2017 Feb; 47(2-3):111-118. PubMed ID: 27899329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium vivax vaccine research: steps in the right direction.
    Higgs ES; Sina B
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):1-2. PubMed ID: 16291759
    [No Abstract]   [Full Text] [Related]  

  • 15. Meeting on planning Plasmodium vivax vaccine efficacy trials. July 20-21, 2004, Singapore.
    Moorthy V; Dubovsky F
    Expert Rev Vaccines; 2006 Feb; 5(1):21-5. PubMed ID: 16451104
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmodium vivax: who cares?
    Galinski MR; Barnwell JW
    Malar J; 2008 Dec; 7 Suppl 1(Suppl 1):S9. PubMed ID: 19091043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From a basic to a functional approach for developing a blood stage vaccine against
    Patarroyo MA; Arévalo-Pinzón G; Moreno-Pérez DA
    Expert Rev Vaccines; 2020 Feb; 19(2):195-207. PubMed ID: 32077349
    [No Abstract]   [Full Text] [Related]  

  • 18. Malaria vaccine clinical trials: what's on the horizon.
    Moreno A; Joyner C
    Curr Opin Immunol; 2015 Aug; 35():98-106. PubMed ID: 26172291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates.
    Sattabongkot J; Tsuboi T; Hisaeda H; Tachibana M; Suwanabun N; Rungruang T; Cao YM; Stowers AW; Sirichaisinthop J; Coleman RE; Torii M
    Am J Trop Med Hyg; 2003 Nov; 69(5):536-41. PubMed ID: 14695092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium vivax pre-erythrocytic vaccines.
    Reyes-Sandoval A
    Parasitol Int; 2021 Oct; 84():102411. PubMed ID: 34166786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.